tradingkey.logo

BRIEF-J&J Says The E.mbrace Study Is Being Discontinued

ReutersFeb 13, 2025 11:22 AM

- Johnson & Johnson JNJ.N:

  • JOHNSON & JOHNSON STATEMENT ON PHASE 3 E.MBRACE STUDY

  • J&J: NO SAFETY SIGNALS RELATED TO THE VACCINE WERE IDENTIFIED.

  • J&J -INDEPENDENT, SCHEDULED REVIEW FINDS INVESTIGATIONAL VACCINE REGIMEN LACKS EFFICACY IN PREVENTING INVASIVE E. COLI DISEASE (IED)

  • J&J: THE E.MBRACE STUDY IS BEING DISCONTINUED

Further company coverage: JNJ.N

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI